Criteria of eligibility of patients with ischemic cardiomyopathy for revascularization and other surgical procedures

N.D. Oryshchyn

References

1. Aklog L, Filsoufi F, Flores K.Q, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation. 2001;104:168-175.
2. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-670.
3. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Amer Coll Cardiology. 2002;39:1151-1158.
4. Athanasuleas CL, Buckberg G.D, Stanley AW, et al. Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev. 2004;9:287-297.
5. Baker DW, Jones R, Hodges J, et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA. 1994;272:1528-1534.
6. Baer FM, Voth E, Schneider CA, et al. Comparison of low-dose dobutamine gradient-echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995;91:1006-1015.
7. Bax JJ, Wijns W, Cornel JH. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J. Amer Coll Cardiology. 1997;30:1451-1460.
8. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:147-186.
9. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis.. Circulation. 2004;110:18-22.
10. Bax JJ, van der Wall EE, Harbinson M. Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart. 2004;90(V):26-33.
11. Beanlands TD, Ruddy RA, de Kamp et al. Positron emission tomography and recovery following revascularization: the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol. 2002;40:1735-1743.
12. Beanlands RS, Chow BJ, Dick A. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease - executive summary. Can J Cardiol. 2007;23:107-119.
13. Beek AM, Kuhl HP, Bondarenko O, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42:895-901.
14. Benedetto U, Melina G, et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. J Cardiovasc. Med. 2009;10 (2):109-114.
15. Bonow RO, Maurer G, Lee Kerry L, Holly TA. Myocardial viability and survival in ischemic left ventricular dysfunction. New Engl J Med. 2011;364:1617-1625.
16. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
17. Buckberg GD. Form versus disease: optimizing geometry during ventricular restoration. Eur. J. Cardiothorac. Surg. 2006;29:238-244.
18. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295-301.
19. Calafiore AM, Iacò AL, Amata D, et al. Left ventricular surgical restoration for anteroseptal scars: volume versus shape. J Thorac Cardiovasc Surg. 2010;139 (5):1123-1130.
20. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997-1004.
21. Carluccio E, Biagioli P, Alunni G, et al. Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. J Am Coll Cardiol. 2006;47:969-977.
22. Chua T. Myocardial viability: strengthening the evidence base. Eur J Nucl Med Mol Imag. 2008;5:2035-2037.
23. Deja MA, Grayburn PA, Sun B, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012;125:2639-2648.
24. Di Donato M, Sabatier M, Dor V, et al. Effects of the Dor procedure on left ventricular dimension and shape and geometric correlates of mitral regurgitation one year after surgery. J Thorac Cardiovasc Surg. 2001;121:91-96.
25. Di Donato, M, Dabic, P, Castelvecchio, S, et al. Left ventricular geometry in normal and post-anterior myocardial infarction patients: sphericity index and ‘new’ conicity index comparisons. Eur J Cardiothorac Surg. 2006;29:225-230.
26. Di Donato M, Castelvecchio S, Menicanti L. End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischemic dilated cardiomyopathy. Eur J Heart Fail. 2010;12:375-381.
27. Dor V, Sabatier M, Montiglio F, et al. Endoventricular patch reconstruction of ischemic failing ventricle. a single center with 20 years experience. advantages of magnetic resonance imaging assessment. Heart Fail Rev. 2004;9:269-286.
28. Elsasser A, Schlepper M, Klovekorn WP, et al. Hibernating myocardium: an incomplete adaptation to ischemia. Circulation. 1997;96:2920-2931.
29. Freeman AP, Walsh WF, Giles RW, et al. Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance. Am J Cardiol. 1984;54:749-754.
30. Hüther J, Doens, T, Nitzsche S, et al. Cardiac magnetic resonance imaging for the assessment of ventricular function, geometry, and viability before and after surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2011;142:1515-1522.
31. Jackson BM, Gorman JH, Moainie SL, et al. Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:1160-1171.
32. Kanzaki H, Bazaz R, Schwartzman D, et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1619-1625.
33. Kawachi K, Kitamura S, Hasegawa J, et al. Increased risk of coronary artery bypass grafting for left ventricular dysfunction with dilated left ventricle. J Cardiovasc Surg. 1997;38:501-505.
34. Kim R, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med. 2000;343:1445-1453.
35. Lancelotti P, Zamorano J-L, Vannan M.A. Imaging challenges in secondary mitral regurgitation unsolved issues and perspectives. Circ Cardiovasc Imaging. 2014;7:735-746.
36. Ling LH, Christian TF, Mulvagh SL, et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium-201 single-photon emission computed tomography, nitroglycerindobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J. 2006;151:882-889.
37. Mandegar MH, Yousefnia MA, Roshanali F, et al. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium. J. Thorac Cardiovasc Surg. 2008;136:930-936.
38. Matsui Y, Fukada Y, Suto Y, et al. Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg. 2002;124:395-397.
39. Maxey T, Reece TB, Ellman P, Butler PD. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428-434.
40. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Amer Coll Cardiology. 1998;32:912-920.
41. Menicanti L, Di Donato M. Surgical left ventricle reconstruction, pathophysiologic insights, results and expectation from the STICH trial. Eur J Cardiothorac Surg. 2004;26:42-47.
42. Nagueh SF, Vaduganathan P, Blaustein A, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol. 1997;29 (5):985-993.
43. Oh JK, Velasquez EJ, Menicanti L, et al. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J. 2013;34:39-47.
44. Pagley GA, Beller DD, Watson LW, Gimple M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793-800.
45. Pegg TJ, Selvanayagam JB, Jennifer J, et al. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularization, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010;12:56.
46. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-221.
47. Ribeiro GA, da Costa CE, Lopes MM, et al. Left ventricular reconstruction benefits patients with ischemic cardiomyopathy and non-viable myocardium. Eur J Cardiothorac Surg. 2006;29:196-201.
48. Schelbert HR, Beanlands R, Bengel F, et al. PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting. J Nucl Cardiol. 2003;10:557-571.
49. Schinkel AF, Poldermans В, Rizello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cadiovasc Surgery. 2004;127:385-390.
50. Selvanayagam B, Kardos A, Francis J, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110:1535-1541.
51. Sharir T, Berman DS, Bax J, et al. Prognostic value of stress myocardial perfusion SPECT in patients with markedly reduced left ventricular function. J Nucl Cardiol. 2006;13(4):495-506.
52. Suma H, Isomura T, Horii T, Nomura F. Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann Thorac Surg. 2006;82:1344-1348.
53. Takeda K, Matsumiya G, Matsue H, et al. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2008;136:1514-1521.
54. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
55. Wakasa S, Matsuia Y, Isomurab T, et al. Impact of left ventricular remodelling on outcomes after left ventriculoplasty for ischaemic cardiomyopathy: Japanese surgical ventricular reconstruction group experience. Interact CardioVasc Thorac Surg. 2013;16:785-791.
56. Yamaguchi A, Ino T, Adachi H, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg. 1998;65:434-438.
57. Ypenburg C, Lancellotti P, Tops LF, et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29:757-765.

Heart rhythm safety of the mononuclear cord blood stem cells transplantation in patients with refractory ischemic heart failure

O.Yu. Usenko, A.V. Yakushev, O.V. Lisun, M.V. Kostylev, V.F. Onishchenko

References

1. Djousse L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA. 2009;302:394–400.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127:6–245.
3. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407–413.
4. Ly HQ, Nattel S. Is stem cell therapy proarrhythmic? Stem Cells Are Not Proarrhythmic Letting the Genie out of the Bottle. Circulation. 2009;119:1824–1831.
5. Peres E, Levine JE, Khaled YA, et al. Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45:149–152.
6. Sanganalmath SK, Bolli R. Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113:810–834.
7. Song-Yan Liao, Hung-Fat Tse Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? Stem Cell Res. Ther. 2013;4:151.
8. Van Laake LW, Passier R, Monshouwer-Kloots J, et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 2007;4:9–24.
9. Vrtovec B, Poglajen G, Sever M, et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail. 2011;17:272–281.
10. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guidline for the Management of Heart Failure. A Report of American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:240–327.

Factors determining quality of life of patients with ischemic cardiomyopathy selected for revascularization procedures

N.B. Іvaniuk, О.J. Zharinov, K.O. Mikhaliev, О.А. Еpanchintseva, B.М. Тоdurov

References

1. Lyakh YuE, Guryanov VG, Khomenko VN. The basics of computer biostatistics: the analysis of information in biology, medicine and pharmacy by statistical package Medstat. Donethsk, 2006. 214 p. (in Rus.).
2. Badar AA, Perez-Moreno AC, Jhund PS, et al. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J. 2014;35:3426-3433.
3. Blankenship JC, Marshall JJ, Pinto DS, et al. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheterization and Cardiovascular Interventions. 2012;1-17.
4. Borkon AM, Muehlebach GF, House J, et al. A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. Ann Thorac Surg. 2002;74(5):1526-1530.
5. Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. New Engl J Med. 2011;364:1016-1026.
6. Dougherty CM, Dewhurst T, Nichol WP, et al. Comparison of three quality of life instruments in stable angina pectoris: the Seattle Angina Questionnarie (SAQ), the Short Form Health Survey (SF-36) and the Quality of Life IndexCardiacVersion III (QLI). J Clin Epidemiol. 1998;51:569-575.
7. Eknoyan G, Lameire N. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Official J International Society Nephrology. 2013;3(1):1-150.
8. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116:I-200-I-206.
9. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease. The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
10. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. New Engl. J. Med. 2001;344(15):1117-1124.
11. Spertus JA, Nerella R, Kettlekamp R, et al. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery. Circulation. 2005;111:768-773.
12. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46(4):517-592.
13. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327.
14. Yang Li-Xia, Zhou Yu-Jie, Wang Zhi-Jian, et al. Impact of invasive treatment strategy on health-related quality of life six months after non-ST-elevation acute coronary syndrome. J Geriatric Cardiology. 2014;11:206-211.
15. Yusuf S, Zucker D, Passamani E, et al. Effect of coronary artery bypass graft surgery on survival overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344 (8922):563-570.
16. Zhang Z, Mahoney EM, Stables RH, et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery. One-year results from the Stentor Surgery trial. Circulation. 2003;108 (14):1694-1700.

Clinical and anamnestic characteristics of patients with clinical manifestations of peripheral artery disease as a function of Т(–786)С polymorphism of the endothelial NO-synthase gene promoter

V.I. Tseluyko, L.M. Yakovleva, O.D. Yarova

References

1. Drozdovska SB. T-786 → with the polymorphism of the promoter of the eNOS gene (endothelial NO-synthase) in Ukrainian athletes. Problems of Ecological and Medical Genetics and Clinical Immunology. 2012;6:46-53. (in Ukr.).
2. Kochetov AG, Lyang OV, Masenko VP, et al. Methods of statistical processing of medical data. Moskva, 2012. 42 p. (in Rus.).
3. Malygina NA, Kostomarova IV, Vodolagina NN, et al. Genes of atherosclerosis and cardiovascular diseases. Clinical Medicine. 2011;89(3):14-18. (in Rus.).
4. Parkhomenko AN, Lutai YaM, Irkin OI, et al. Clinical and diagnostic significance of endothelial NO synthetase gene polymorphism in patients with acute coronary syndromes. Emergency medicine. 2014;3(58):45-54. (in Rus.).
5. Tseluyko VY, Yakovleva LM. Clinical characteristics and comparative estimation of atherosclerotic lesion of different vascular basins in patients with chronic ischemic heart disease depending on polymorphism T (-786) With promoter of endothelial NO synthase. Serce i sudyny [Heart and vessels]. 2013;4:95-102. (in Ukr.).
6. Telyuko VYa, Yakovleva LM, Bondar TM. The role of T-786C polymorphism of endothelial NO synthase gene in disturbances of nitrous oxide metabolism and atherosclerosis development. Ukr Cardiol J. 2012;4:69-73. (in Ukr.).
7. Tseluiko VY, Yakovleva LM. Influence of endophthalmic NO-synthase T-786C polymorphism on the prognosis and efficacy of statins in patients with coronary heart disease during long-term observation. Medicine of Ukraine. 2013;9-10(175-176):90-93. (in Ukr.).
8. Bhatt DL, Eagle KA, Ohman EM. et al. REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. J Amer Med Association. 2010;304(12):1350-1357.
9. Forstermann U, Sessa W. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33:829-837.
10. Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242-1257.
11. Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease / A Report of the American College of Cardiology Foundation. J Amer Coll Cardiology. 2012;59(3):294-353.
12. Kovacic S, Bakran M. Genetic Susceptibility to Atherosclerosis. Stroke Research and Treatment. 2012;2012:5.
13. Leeper N, Kullo I, Cooke J. Genetics of peripheral artery disease. Circulation. 2012;125:3220-3228.
14. Lieb W, Vasan RS. Genetics of coronary artery disease. Circulation. 2013;128(10):1131-1138.
15. Tsujimura Т, Ishihara Т, Iida О, et al. Syntax score is an independent predictor of 4-years mortality in patients with peripheral artery disease. J Amer Coll Cardiology. 2015;65(10).
16. Wang TJ. Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction. Circulation. 2011;123:551-565.

Dynamic renoscintigraphy in cardiology and cardiac surgery

V.Yu. Kundin, I.V. Noverko, A.G. Mazur

References

1. Agranovich NV, Anopchenko AS, Pustovay DV, Pilipovich LA Early diagnosis of kidney damage in hypertension in elderly patients. International Journal of Applied and Fundamental Research. 2014;11:817–819. (in Rus.).
2. Batyushin MM, Levitskaya ES, Terentyev VP et al. Prediction of cardiovascular risk in patients with IHD who underwent myocardial revascularization surgery, taking into account the presence of renal and cardiovascular risk factors. Clinical Nephrology. 2011;1:39–42. (in Rus.).
3. Zharinov OJ. The risk of cardiovascular events in patients with arterial hypertension and kidney damage. Arterial hypertension. 2008;1:11–14. (in Ukr.).
4. Clinical Radiography. Мoskva: Мedicina, 1985;4. 368 р. (in Rus.).
5. Kolesnik MO, Lawny KM. Cardiorenal syndrome: a new approach to the old problem. Ukr. J. Nephrology and Dialysis. 2009;4 (24):25–34. (in Ukr.).
6. Kundin VYu, Stepanova NM, Nikolov MO, Tycholoz SP. Features of estimation of geometric sizes of kidneys with neurotropic radiopharmaceuticals. Radiation diagnostics, radiotherapy. 2005;2:43–48. (in Ukr.).
7. Parkhomenko OM, Gurieva OS. Renal dysfunction as a marker of an unfavorable course of myocardial infarction. Serce i sudyny [Heart and vessels]. 2008;3:51–59. (in Ukr.).
8. Pytel YuA, Zolotarev II. Errors and complications in the X-ray examination of the kidneys and urinary tract. Мoskva: Мedicina, 1987. 256 p. (in Rus.).
9. Radionuclide diagnostics for practical doctors. Eds by Lishmanov Yu.B, Chernov VI. Tomsk: STT, 2004. 394 p. (in Rus.).
10. Calculation and recording of the individual effective dose of radiation from the patient from radionuclide diagnostic procedures. Kharkiv, 1995. 21 p. (in Ukr.).
11. Guidelines for physicians referring patients to a radiological study. Кyiv: Medicine of Ukraine, 2000. 102 p. (in Rus.).
12. Samoylenko LE, Sergienko VB. The Role of Radionuclide Research Methods in Arterial Hypertension. Systemic Hypertension. 2007;2:47–54. (in Rus.).
13. Sigitova ON, Bogdanova AR, Arkhipov EV, Saubanova E.I. Evaluation of the effect of arterial hypertension, hyperlipidemia on the formation of nephropathy in coronary heart disease. Practical medicine. 2012;8(64):157–160. (in Rus.).
14. Sirenko YuN. Symptomatic arterial hypertension. Ukrainian Medical Journal. 2008;3(65):48–79. (in Rus.).
15. Skoromnaya AS. Successful myocardial revascularization in patients with various clinical forms of IHD and proteolysis activity: the effect of renal dysfunction. Journal of the Grodno State Medical University. 2013;2(42):61–64. (in Rus.).
16. ACR Standart Book by the Committee on Standards of the Commission on Nuclear Medicine. Renal Scintigraphy. 1999:481–484.
17. ACR STANDARDS. Radiopharmaceuticals. ACR Standards for diagnostic procedures using radiopharmaceuticals. 2002:427–432.
18. Prigent A, Cosgriff P, Gates GF. et al. Concensus report on quality control of quantitative measurereme of renal function obtained from the renogram : International Consensus from the Scientific Committee of Radionuclides in Nephrology. Semin. Nucl. Med. 1999;29(2):146–159.
19. Dar О, Cowie MR. Acute heart failure in the intensive care unit epidemiology. Crit. Care Med. 2008;36:93–98.
20. Society of Nuclear Medicine Procedure Guideline for Diagnosis of Renovascular Hypertension 2.0Society of Nuclear Medicine procedure guidelines manual 2001-2002. Renovascular hypertension. 2002:81–86.

New in recommendations on primary percutaneous coronary intervention for myocardial infarction with ST segment elevation

M.Т. Vatutin, Y.V. Yeshchenko, K.S. Gasendich, Yu.P. Gritsenko

Source

Levine GN, O’Gara PT, Bates ER, et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016;133:1135–1147.

Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology

V.-P. Harjola, A. Mebazaa, J. Čelutkienė, D. Bettex, H. Bueno, O. Chioncel, M. Crespo-Leiro, V. Falk, G. Filippatos, S. Gibbs, A. Leite-Moreira, J. Lassus, J. Masip, C. Mueller, W. Mullens, R. Naeije, A.V. Nordegraaf, J. Parissis, J. Riley, A. Ristic, G. Rosano, A. Rudiger, F. Ruschitzka, P. Seferovic, B. Sztrymf, A. Vieillard-Baron, M. Yilmaz, S. Konstantinides

References

1. 1. Abe S, Yoshihisa A, Takiguchi M, et al. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure. PLoS One. 2014;9:e100618.
   2. Aiken LH, Sloane DM, Bruyneel L, et al. Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study. Lancet. 2014;383:1824-1830.
   3. Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv. 2006;68:78-82.
   4. Ayuela Azcarate JM, Clau TF, Ochagavia A, Vicho PR. Role of echocardiography in the hemodynamic monitorization of critical patients. Med Intensiva. 2012;36:220-232.
   5. Belohlavek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18:129-138.
   6. Berlin DA, Bakker J. Understanding venous return. Intensive Care Med. 2014;40:1564-1566.
   7. Bodson L, Bouferrache K, Vieillard-Baron A. Cardiac tamponade. Curr Opin Crit Care. 2011;17:416-424.
   8. Boissier F, Katsahian S, Razazi K, et al. Prevalence and prognosis of cor pulmonale during protective ventilation for acute respiratory distress syndrome. Intensive Care Med. 2013;39:1725-1733.
   9. Bowers TR, O’Neill WW, Grines C, et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. New Engl J Med. 1998;338:933-940.
   10. Bowers TR, O’Neill WW, Pica M, Goldstein JA. Patterns of coronary compromise resulting in acute right ventricular ischemic dysfunction. Circulation. 2002;106:1104-1109.
   11. Breidthardt T, Vanpoucke G, Potocki M, et al. The novel marker LTBP2 predicts all-cause and pulmonary death in patients with acute dyspnoea. Clin Sci (Lond). 2012;123:557-566.
   12. Brodie BR, Stuckey TD, Hansen C, et al. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol. 2007;99:431-435.
   13. Bueno H, Lopez-Palop R, Bermejo J, et al. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation. 1997;96:436-441.
   14. Bueno H, Lopez-Palop R, Perez-David E, et al. Delcan JL. Combined effect of age and right ventricular involvement on acute inferior myocardial infarction prognosis. Circulation. 1998;98:1714-1720.
   15. Candilio L, Malik A, Ariti C, et al. A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart? J Cardiothorac Surg. 2014;9:1484.
   16. Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am Heart J. 1989;117:1140-1146.
   17. Chandraratna PA, Mohar DS, Sidarous PF. Role of echocardiography in the treatment of cardiac tamponade. Echocardiography. 2014;31:899-910.
   18. Chen JM, Levin HR, Rose EA, et al. Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg. 1996;61:305-310.
   19. Cheung AW, White CW, Davis MK, Freed DH. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes. J Heart Lung Transplant. 2014;33:794-799.
   20. Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J. 2011;162:142-153.
   21. Dalabih M, Rischard F, Mosier J. What’s new: the management of acute right ventricular decompensation of chronic pulmonary hypertension. Intensive Care Med. 2014;40:1930-1933.
   22. Damman K, Navis G, Smilde TD, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9:872-878.
   23. Damman K, van Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582-588.
   24. Dell’Italia LJ, Lembo NJ, Starling MR, et al. Hemodynamically important right ventricular infarction: follow-up evaluation of right ventricular systolic function at rest and during exercise with radionuclide ventriculography and respiratory gas exchange. Circulation. 1987;75:996-1003.
   25. Deuse T, Schirmer J, Kubik M, Reichenspurner H. Isolated permanent right ventricular assistance using the HVAD continuous-flow pump. Ann Thorac Surg. 2013;95:1434-1436.
   26. Galie N, Humbert M, Vachiery J.L et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67-119.
   27. Gayat E, Mebazaa A. Pulmonary hypertension in critical care. Curr Opin Crit Care. 2011;17:439-448.
   28. George I, Xydas S. Topkara VK, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg. 2006;82:2161-2169.
   29. Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology. 1984;60:132-135.
   30. Ghio S, Klersy C, Magrini G, et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol. 2010;140:272-278.
   31. Giannitsis E, Potratz J,Wiegand U, et al. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction. Heart. 1997;77:512-516.
   32. Goldstein JA, Barzilai B, Rosamond TL, et al. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation. 1990;82:359-368.
   33. Goldstein JA, Harada A, Yagi Y, et al. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol. 1990;16:181-189.
   34. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521-528.
   35. Green EM, Givertz MM. Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep. 2012;9:228-235.
   36. Griffith KE, Jenkins E, Stulak J, et al. Long-term use of the CentriMag(R) Ventricular Assist System as a right ventricular assist device: a case report. Perfusion. 2012;27:65-70.
   37. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-3128.
   38. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: I. Anatomy, physiology, and assessment. Anesth Analg. 2009;108:407-421.
   39. Haddad F, Couture P, Tousignant C, Denault AY. The right ventricle in cardiac surgery, a perioperative perspective: II. Pathophysiology, clinical importance, and management. Anesth Analg. 2009;108:422-433.
   40. Haddad F, Hunt S, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436-1448.
   41. Haddad F, Peterson T, Fuh E, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail. 2011;4:692-699.
   42. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:1717-1731.
   43. Heydari AA, Safari H, Sarvghad MR. Isolated tricuspid valve endocarditis. Int J Infect Dis. 2009;13:e109-e111.
   44. Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184:1114-1124.
   45. Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med. 2011;184:1114-1124.
   46. Jacobs AK, Leopold JA, Bates E, et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003;41:1273-1279.
   47. Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265-2271.
   48. Jardin F, Vieillard-Baron A. Is there a safe plateau pressure in ARDS? The right heart only knows. Intensive Care Med. 2007;33:444-447.
   49. Jurcut R, Giusca S, La GA, et al. The echocardiographic assessment of the right ventricle: what to do in 2010? Eur J Echocardiogr. 2010;11:81-96.
   50. Kapur NK, Paruchuri V, Jagannathan A, et al. Mechanical circulatory support for right ventricular failure. JACC Heart Fail. 2013;1:127-134.
   51. Kelly DM, Kutney-Lee A, McHugh MD, et al. Impact of critical care nursing on 30-day mortality of mechanically ventilated older adults. Crit Care Med. 2014;42:1089-1095.
   52. Kiernan MS, French AL, DeNofrio D, et al. Preoperative three-dimensional echocardiography to assess risk of right ventricular failure after left ventricular assist device surgery. J Card Fail. 2015;21:189-197.
   53. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med. 1994;330:1211-1217.
   54. Kinn JW, Ajluni SC, Samyn JG, et al. Rapid hemodynamic improvement after reperfusion during right ventricular infarction. J Am Coll Cardiol. 1995;26:1230-1234.
   55. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033-3069.
   56. Krabatsch T, Potapov E, Stepanenko A, et al. Biventricular circulatory support with two miniaturized implantable assist devices. Circulation. 2011;124:S179-S186.
   57. Kucher N, Boekstegers P, Muller O.J, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129:479-486.
   58. Kurzyna M, Zylkowska J, Fijalkowska A, et al. Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. Kardiol Pol. 2008;66:1033-1039.
   59. Lancellotti P, Price S, Edvardsen T, et al. The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. Eur. Heart J Acute Cardiovasc Care. 2015;16:119-146.
   60. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1-39.
   61. Lankeit M, Friesen D, Aschoff J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J. 2010;31:1836-1844.
   62. Lankeit M, Jimenez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011;124:2716-2724.
   63. Lankeit M, Kempf T, Dellas C, et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2008;177:1018-1025.
   64. Laster SB, Ohnishi Y, Saffitz JE, Goldstein JA. Effects of reperfusion on ischemic right ventricular dysfunction. Disparate mechanisms of benefit related to duration of ischemia. Circulation. 1994;90:1398-1409.
   65. Laster SB, Shelton TJ, Barzilai B, Goldstein JA. Determinants of the recovery of right ventricular performance following experimental chronic right coronary artery occlusion. Circulation. 1993;88:696-708.
   66. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90:1405-1409.
   67. Lewis JF, Webber JD, Sutton LL, et al. Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: recognition and clinical implications. J Am Coll Cardiol. 1993;21:649-654.
   68. Lheritier G, Legras A, Caille A, et al. Prevalence and prognostic value of acute cor pulmonale and patent foramen ovale in ventilated patients with early acute respiratory distress syndrome: a multicenter study. Intensive Care Med. 2013;39:1734-1742.
   69. Liang M, Chin J, Pasupati S. Complete heart block in late presentation of inferior STEMI successfully treated with percutaneous coronary intervention. J Invasive Cardiol. 2011;23:E219-E221.
   70. Logeart D, Isnard R, Resche-Rigon M, et al. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study. Eur J Heart Fail. 2013;15:465-476.
   71. Maggioni AP, Dahlstrom U, Filippatos G, et al. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2010;12:1076-1084.
   72. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824-839.
   73. Markel TA, Wairiuko GM, Lahm T, et al. The right heart and its distinct mechanisms of development, function, and failure. J Surg Res. 2008;146:304-313.
   74. Marzec LN, Ambardekar AV. Preoperative evaluation and perioperative management of right ventricular failure after left ventricular assist device implantation. Semin Cardiothorac Vasc Anesth. 2013;17:249-261.
   75. Mayo PH, Beaulieu Y, Doelken P, et al. American College of Chest Physicians/La Societe de Reanimation de Langue Francaise statement on competence in critical care ultrasonography. Chest. 2009;135:1050-1060.
   76. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation. 2002;106:1477-1482.
   77. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803-869.
   78. Mebazaa A, Yilmaz MB. Levy P, et al. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail. 2015;17:544-558.
   79. Megalla S, Holtzman D, Aronow WS, et al. Predictors of cardiac hepatopathy in patients with right heart failure. Med Sci Monit. 2011;17:CR537-CR541.
   80. Mehta SR, Eikelboom JW, Natarajan MK, et al. Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction. J Am Coll Cardiol. 2001;37:37-43.
   81. Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. New Engl J Med. 2014;370:1402-1411.
   82. Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1493-1501.
   83. Morelli A, Teboul JL, Maggiore SM, et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med. 2006;34:2287-2293.
   84. Moreyra AE, Horvitz L, Presant SB, Kostis JB. Resolution of complete heart block after right coronary artery angioplasty. Am Heart J. 1988;115: 179-181.
   85. Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-596.
   86. Naeije R, Brimioulle S, Dewachter L. Biomechanics of the right ventricle in health and disease (2013 Grover Conference series). Pulm Circ. 2014;4:395-406.
   87. Naito A, Tanabe N, Jujo T, et al. Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism. PLoS One. 2014;9:e113086.
   88. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term Survival. J Am Coll Cardiol. 2004;43:405-409.
   89. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27:2725-2736.
   90. Park SJ, Park JH, Lee HS, et al. Impaired RV global longitudinal strain is associated with poor long-term clinical outcomes in patients with acute inferior STEMI. JACC Cardiovasc. Imaging. 2015;8:161-169.
   91. Pegg TJ, Selvanayagam JB, Karamitsos TD, et al. Effects of off-pump versus on-pump coronary artery bypass grafting on early and late right ventricular function. Circulation. 2008;117:2202-2210.
   92. Price LC, Wort SJ. Finney SJ, et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010;14:R169.
   93. Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur. Heart J. 2007;28:224-229.
   94. Rajaram SS, Desai NK, Kalra A, et al. Pulmonary artery catheters for adult patients in intensive Care. Cochrane Database Syst Rev. 2013;2:CD003408.
   95. Rajdev A, Garan H, Biviano A. Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012;55:180-186.
   96. Ramamurthy S, Anandaraja S, Matthew N. Percutaneous coronary intervention for persistent complete heart block complicating inferior myocardial infarction. J. Invasive Cardiol. 2007;19:E372-E374.
   97. Ristic AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35:2279-2284.
   98. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685-713.
   99. Sandoval J, Torbicki A. Atrial Septostomy. The Right Ventricle in Health and Disease / Eds. N. Voelkel, D. Schranz. N.Y.: Humana Press, Springer. 2015:419-437.
   100. Schurner A, Wilhelm MJ, Falk V, et al. Recurrent clotting of a continuous-flow right ventricular assist device: repeated thrombolysis with two different protocols. J Cardiothorac Vasc Anesth. 2015;29:1614-1617.
   101. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-S39.
   102. Song HK, von HC, Jespersen CM, et al. Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. Ann Thorac Surg. 2014;97:1630-1635.
   103. Spinar J, Parenica J, Vitovec J, et al. Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry. Crit Care. 2011;15:R291.
   104. Sztrymf B, Prat D, Jacobs FM, et al. Renal replacement therapy in patients with severe precapillary pulmonary hypertension with acute right heart failure. Respiration. 2013;85:464-470.
   105. Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35:1286-1293.
   106. Topol EJ, Goldschlager N, Ports TA, et al. Hemodynamic benefit of atrial pacing in right ventricular myocardial infarction. Ann Intern Med. 1982;96:594-597.
   107. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1-44.
   108. Van Deursen VM, Damman K, Hillege HL, et al. Abnormal liver function in relation to hemodynamic profile in heart failure Patients. J Card Fail. 2010;16:84-90.
   109. Ventetuolo CE, Klinger JR. Management of acute right ventricular failure in the intensive care unit. Ann Am Thorac Soc. 2014;11:811-822.
   110. Verbrugge FH, Dupont M, Steels P, et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol. 2013;62:485-495.
   111. Vieillard-Baron A, Price L.C, Matthay M.A. Acute cor pulmonale in ARDS. Intensive Care Med. 2013;39:1836-1838.
   112. Vieillard-Baron A, Prin S, Chergui K, et al. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med. 2002;166:1310-1319.
   113. Vieillard-Baron A, Schmitt JM, Augarde R, et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001;29:1551-1555.
   114. Vlahakes GJ. Right ventricular failure following cardiac surgery. Coron Artery Dis. 2005;16:27-30.
   115. Voelkel NF, Gomez-Arroyo J, Abbate A, Bogaard HJ. Mechanisms of right heart failure - a work in progress and a plea for failure prevention. Pulm Circ. 2013;3:137-143.
   116. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecularmechanisms of right heart failure. Circulation. 2006;114:1883-1891.
   117. Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62:D22-D33.
   118. Walker LA, Buttrick PM. The right ventricle: biologic insights and response to disease: updated. Curr Cardiol Rev. 2013;9:73-81.
   119. Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2014;35:156-167.
   120. Wesley RC, Jr, Lerman BB, DiMarco JP, et al. Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol. 1986;8:1232-1234.
   121. West E, Barron D.N, Harrison D, et al. Nurse staffing, medical staffing and mortality in intensive care: an observational study. Int J Nurs Stud. 2014;51:781-794.
   122. Zehender M, Kasper W, Kauder E, et al. Eligibility for and benefit of thrombolytic therapy in inferior myocardial infarction: focus on the prognostic importance of right ventricular infarction. J Am Coll Cardiol. 1994;24:362-369.
   123. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. New Engl J Med. 1993;328:981-988.